Amicus Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 29,452 | 0.00909% |
Individual Insiders | 1,802,124 | 0.556% |
VC/PE Firms | 28,057,456 | 8.66% |
Hedge Funds | 42,228,321 | 13% |
Institutions | 251,951,008 | 77.7% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 4.5%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
28,492,486 | US$296.3m | 5.01% | 0.01% | |||
28,057,456 | US$291.8m | 1.32% | 6.62% | |||
27,400,000 | US$285.0m | 0% | 4.08% | |||
22,988,139 | US$239.1m | 9.77% | no data | |||
16,994,474 | US$176.7m | 37.8% | 0.02% | |||
15,190,024 | US$158.0m | 102% | 0.02% | |||
14,828,321 | US$154.2m | -12.5% | 6.21% | |||
13,163,085 | US$136.9m | 15.8% | 0.01% | |||
12,662,821 | US$131.7m | 22.3% | 0.02% | |||
11,687,941 | US$121.6m | 12.3% | 0.17% | |||
11,507,129 | US$119.7m | -23% | 0.05% | |||
10,373,715 | US$107.9m | -1.43% | 11.7% | |||
7,215,010 | US$75.0m | 0.03% | 0.08% | |||
6,994,597 | US$72.7m | -16.7% | 0.05% | |||
5,951,295 | US$61.9m | 6.16% | 0.01% | |||
5,778,744 | US$60.1m | 3,840% | 0.03% | |||
5,222,329 | US$54.3m | 3.17% | 0.13% | |||
4,582,067 | US$47.7m | 5.48% | 0.03% | |||
2,844,751 | US$29.6m | 0.45% | no data | |||
2,531,000 | US$26.3m | -53.1% | no data | |||
2,500,000 | US$26.0m | 19.3% | 0.02% | |||
2,415,090 | US$25.1m | 32.5% | 0.01% | |||
2,268,886 | US$23.6m | 0% | no data | |||
2,194,382 | US$22.8m | -21% | no data | |||
2,026,364 | US$21.1m | -50.1% | 0.6% |